Array Bridge Inc. is a biotechnology startup based in the United States, founded in 2010. The company's slogan "Your path to success" aligns with its focus on providing quality products and services for the pharmaceutical and biotechnology industry. Array Bridge offers a range of products, including antibody arrays for biosimilar and antibody-drug conjugate (ADC) three-dimensional (3-D) conformational comparability analysis, as well as ELISA kits for Host Cell Proteins, including CHO and E. coli-derived biologics. In addition to products, the company also provides services such as antibody production, Host Cell Protein, and binding-based bioassay method qualification and validation, 1-D and 2-D gel analysis of process-related impurities, Western Blot analysis of HCPs, and residual DNA and Protein A analysis. Array Bridge Inc. received its last investment in the form of a grant investment at 01 January 2012, with the BioGenerator being the investors. With its focus on serving the biotechnology and pharmaceutical industry, the company has positioned itself as a key player in providing essential products and services to support research and development in these highly specialized fields.
No recent news or press coverage available for Array Bridge Inc..